Researchers Shed Light on How to Predict Which Skin Cancer Patients Are Most Likely to Respond to Immunotherapy Jan. 8, 2025 — An international team of UK and US scientists discovered that the ...

Immunotherapy uses a person's own immune system to fight cancer. Immune checkpoint inhibitors are one class of immunotherapy ...

One poster presentation provides further insights on the mode of action of IO102-IO103, the company's lead investigational therapeutic cancer vaccine which targets cells expressing IDO1 and PD-L1, ...

Bristol Myers Squibb (BMS) has announced that its dual immunotherapy combination has been recommended by the National Institute for Health and Care Excellence (NICE) as a first-line treatment for a ...

Credit: SciTechDaily.com USC researchers have developed an innovative type of cancer-fighting immune cell, the EchoBack CAR T-cell, that uses focused ultrasound to activate and sustain ... advance in ...

But that doesn't appear to hinder the effectiveness of immunotherapy for cancer in seniors, a new study says. Seniors with cancer respond just as well as younger patients to immune checkpoint ...

Researchers have developed an innovative nano-immune agonist that significantly improves immunotherapy ... the cGAS-STING signaling pathway, a key player in innate immune activation.

Prof. WU Zhengyan from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, in collaboration with ...

FDA approved Imfinzi with gemcitabine and cisplatin for muscle-invasive bladder cancer, based on NIAGARA trial results showing improved survival outcomes. The regimen integrates immunotherapy in pre- ...

Beijing National Laboratory for Molecular Sciences, CAS Key Laboratory of Colloid, Interface and Chemical Thermodynamics, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, China ...